Jeremy Bender Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity

DAWN Quotes by TradingView

Jeremy Bender is CHIEF EXECUTIVE OFFICER of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 161,365 shares of DAWN, which is worth approximately $1.21 Million. The most recent transaction as insider was on Mar 07, 2023, when has been sold 12,500 shares (Common Stock) at a price of $20.01 per share, resulting in proceeds of $250,125. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 161K
10.72% 3M change
63.11% 12M change
Total Value Held $1.21 Million

Jeremy Bender Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2023
SELL
Open market or private sale
$250,125 $20.01 p/Share
12,500 Reduced 1.05%
1,174,276 Common Stock
Feb 16 2023
SELL
Open market or private sale
$59,140 $19.57 p/Share
3,022 Reduced 0.25%
1,186,776 Common Stock
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
8,312 Added 0.69%
1,189,798 Common Stock
Jan 23 2023
SELL
Open market or private sale
$275,000 $22.0 p/Share
12,500 Reduced 1.05%
1,181,486 Common Stock
Dec 21 2022
SELL
Open market or private sale
$254,000 $20.32 p/Share
12,500 Reduced 1.04%
1,192,424 Common Stock
Nov 21 2022
SELL
Open market or private sale
$263,250 $21.06 p/Share
12,500 Reduced 1.03%
1,204,924 Common Stock
Nov 16 2022
SELL
Open market or private sale
$32,468 $21.46 p/Share
1,513 Reduced 0.12%
1,217,424 Common Stock
Nov 15 2022
BUY
Exercise of conversion of derivative security
-
3,562 Added 0.29%
1,218,937 Common Stock
Nov 01 2022
SELL
Open market or private sale
$250,375 $20.03 p/Share
12,500 Reduced 1.02%
1,215,375 Common Stock
Oct 03 2022
SELL
Open market or private sale
$250,625 $20.05 p/Share
12,500 Reduced 1.01%
1,227,875 Common Stock
Sep 01 2022
SELL
Open market or private sale
$293,375 $23.47 p/Share
12,500 Reduced 1.0%
1,240,375 Common Stock
Sep 01 2022
SELL
Open market or private sale
$293,375 $23.47 p/Share
12,500 Reduced 1.0%
1,240,375 Common Stock
Aug 16 2022
SELL
Open market or private sale
$97,313 $24.31 p/Share
4,003 Reduced 0.32%
1,252,875 Common Stock
Aug 15 2022
BUY
Exercise of conversion of derivative security
-
10,686 Added 0.84%
1,256,878 Common Stock
Aug 04 2022
SELL
Open market or private sale
$250,000 $20.0 p/Share
12,500 Reduced 0.99%
1,246,192 Common Stock
Jul 18 2022
SELL
Open market or private sale
$52,000 $20.0 p/Share
2,600 Reduced 0.21%
1,258,692 Common Stock
Jul 08 2022
SELL
Open market or private sale
$35,900 $20.0 p/Share
1,795 Reduced 0.14%
1,261,292 Common Stock
Jul 05 2022
SELL
Open market or private sale
$17,140 $20.0 p/Share
857 Reduced 0.07%
1,263,087 Common Stock
Jul 01 2022
SELL
Open market or private sale
$34,920 $20.0 p/Share
1,746 Reduced 0.14%
1,263,944 Common Stock

Also insider at

FUSN
Fusion Pharmaceuticals Inc. Healthcare
MREO
Mereo Biopharma Group plc Healthcare
JB

Jeremy Bender

CHIEF EXECUTIVE OFFICER
South San Francisco, CA

Track Institutional and Insider Activities on DAWN

Follow Day One Biopharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

News

Receive news related to Day One Biopharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DAWN